4Indexed trials
drug · Product Intelligence
Buspirone
Pipeline Intelligence
Buspirone: 4 indexed trials, 4 sponsors; 0 linked Orange Book patents and 6 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
6FDA-linked events
Development evidence
NCT01496612National Institute of Neurological Disorders and Stroke (NINDS) · epilepsyPHASE2
NCT01641159University of Cincinnati · other_psychiatryPHASE2
NCT02803749University of Rochester · parkinsonsPHASE2
NCT03432065Massachusetts General Hospital · autismPHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALBUSPIRONE HYDROCHLORIDE · 2025-10-06
FDA_APPROVALBUSPIRONE HYDROCHLORIDE · 2025-07-03
FDA_APPROVALBUSPIRONE HYDROCHLORIDE · 2017-05-24
FDA_APPROVALBUSPIRONE HYDROCHLORIDE · 2007-12-17
FDA_APPROVALBUSPIRONE HYDROCHLORIDE · 2002-02-27
FDA_APPROVALBUSPAR · 2000-12-20
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.